Using mass spectrometry to validate mouse models of tauopathy

Using mass spectrometry to validate mouse models of tauopathy

Bibliographic Details
Main Authors:	Yan Yan, Casey N. Cook
Format:	Article
Language:	English
Published:	BMC 2023-04-01
Series:	Molecular Neurodegeneration
Subjects:	Tau Alzheimer’s disease Frontotemporal dementia Phosphorylation Mouse model Tauopathy
Online Access:	https://doi.org/10.1186/s13024-023-00615-6

Similar Items

Common mouse models of tauopathy reflect early but not late human disease
by: Kathrin Wenger, et al.
Published: (2023-02-01)

Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy
by: Naruhiko Sahara, et al.
Published: (2023-04-01)

<i>Caenorhabditis elegans</i> Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies
by: Carmina Natale, et al.
Published: (2020-11-01)

Novel aspects of the phosphorylation and structure of pathological tau: implications for tauopathy biomarkers
by: Taeko Kimura, et al.
Published: (2024-02-01)

Tau protein profiling in tauopathies: a human brain study
by: Juan Lantero-Rodriguez, et al.
Published: (2024-07-01)

Tau interactome and RNA binding proteins in neurodegenerative diseases
by: Tomas Kavanagh, et al.
Published: (2022-10-01)

Early impairments of visually-driven neuronal ensemble dynamics in the rTg4510 tauopathy mouse model
by: Aleksandra Parka, et al.
Published: (2023-03-01)

Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy
by: L. Arouche-Delaperche, et al.
Published: (2023-01-01)

Heparan Sulfate Proteoglycans in Tauopathy
by: Yanan Zhu, et al.
Published: (2022-11-01)

Glial contributions to neurodegeneration in tauopathies
by: Cheryl E. G. Leyns, et al.
Published: (2017-06-01)

Ferritin nanocage-enabled detection of pathological tau in living human retinal cells
by: Lorenzo Barolo, et al.
Published: (2024-05-01)

Targeting tauopathy with engineered tau-degrading intrabodies
by: Gilbert Gallardo, et al.
Published: (2019-10-01)

Novel autoimmune response in a tauopathy mouse model
by: Carlos J Nogueras-Ortiz, et al.
Published: (2014-01-01)

Astrocytes in Tauopathies
by: Matthew J. Reid, et al.
Published: (2020-09-01)

Evaluating the efficacy of purchased antisense oligonucleotides to reduce mouse and human tau in vivo
by: Pranav Vemula, et al.
Published: (2023-12-01)

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
by: Yijun Chen, et al.
Published: (2023-07-01)

Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice
by: Taiki Kambe, et al.
Published: (2011-06-01)

Structural MRI Reveals Cervical Spinal Cord Atrophy in the P301L Mouse Model of Tauopathy: Gender and Transgene-Dosing Effects
by: Thomas Sartoretti, et al.
Published: (2022-05-01)

Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
by: Seyedeh Maryam Alavi Naini, et al.
Published: (2018-03-01)

Mouse serum albumin induces neuronal apoptosis and tauopathies
by: Sheng-jie Hou, et al.
Published: (2024-04-01)

Loss of Smek1 Induces Tauopathy and Triggers Neurodegeneration by Regulating Microtubule Stability
by: Ruo‐Nan Duan, et al.
Published: (2024-10-01)

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
by: Shengnan Zhang, et al.
Published: (2022-09-01)

DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
by: Geraldine Zimmer-Bensch, et al.
Published: (2021-11-01)

Truncated tau disrupts autophagy and endolysosomal systems
by: Saskia J. Pollack, et al.
Published: (2024-12-01)

Tau; One Protein, So Many Diseases
by: Parisa Tabeshmehr, et al.
Published: (2023-02-01)

Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development and therapeutic targeting
by: Liara Rizzi, et al.
Published: (2024-02-01)

Editorial: Untangling the Role of Tau in Physiology and Pathology
by: Miguel Medina, et al.
Published: (2020-05-01)

Genetic ablation of tau in postnatal neurons rescues decreased adult hippocampal neurogenesis in a tauopathy model
by: Sarah Houben, et al.
Published: (2019-07-01)

Induction of tauopathy in a mouse model of amyloidosis using intravenous administration of adeno‐associated virus vectors expressing human P301L tau
by: Dylan J. Finneran, et al.
Published: (2024-04-01)

Tauopathies: A Distinct Class of Neurodegenerative Diseases
by: Ozansoy M, et al.
Published: (2007-01-01)

YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
by: Marta Querol-Vilaseca, et al.
Published: (2017-06-01)

Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17
by: Debby Van Dam, et al.
Published: (2023-10-01)

Nicotinamide mononucleotide adenylyltransferase uses its NAD+ substrate-binding site to chaperone phosphorylated Tau
by: Xiaojuan Ma, et al.
Published: (2020-04-01)

Glutamatergic nervous system degeneration in a C. elegans TauA152T tauopathy model involves pathways of excitotoxicity and Ca2+ dysregulation
by: Bikash Choudhary, et al.
Published: (2018-09-01)

Antisense oligonucleotide-based targeting of Tau-tubulin kinase 1 prevents hippocampal accumulation of phosphorylated tau in PS19 tauopathy mice
by: Kayo Yukawa, et al.
Published: (2023-10-01)

Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook
by: Miriam Conte, et al.
Published: (2023-05-01)

Oxidative Stress in Tauopathies: From Cause to Therapy
by: Fernando Bartolome, et al.
Published: (2022-07-01)

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
by: Edward Rockenstein, et al.
Published: (2014-07-01)

The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer’s disease
by: Yao Sun, et al.
Published: (2020-02-01)

Chemoinformatics Analyses of Tau Ligands Reveal Key Molecular Requirements for the Identification of Potential Drug Candidates against Tauopathies
by: Luca Pinzi, et al.
Published: (2021-08-01)